A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH
Keyword(s):
1972 ◽
Vol 247
(10)
◽
pp. 3114-3122
2004 ◽
Vol 50
(6)
◽
pp. 561-568
◽
Keyword(s):
2011 ◽
Vol 29
(5)
◽
pp. 906-914
◽
1981 ◽
Vol 33
(1)
◽
pp. 445-450
◽
2018 ◽
Vol 51
(12)
◽
1993 ◽
Vol 91
(4)
◽
pp. 1516-1520
◽